A new approach to treating blood cancer just got a promising set of results (BLUE)
|12/11/2017||Posted by BusinessMediaguide.Com under General World News||
- Researchers are looking for new ways to approach blood cancers.
- One of those ways is a target called BCMA, short for “B-cell maturation antigen,” that’s integral to a cancer called multiple myeloma.
- Interest in BCMA has been “building” according to industry experts, as companies like GSK and Bluebird Bio release more data on their experimental treatments.
Biotech companies are working to develop new treatments for hard-to-treat forms of blood cancer.
In particular, a set of experimental treatments is going after a target called B-cell maturation antigen. The protein is expressed primarily in patients with multiple myleoma, a form of blood cancer read more >>>